1. Samuels, Joshua D, Moore, Katelyn A, Ennerfelt, Hannah E, Price, Richard J, Lukens, John R. 2023. The Alzheimer's disease risk factor INPP5D restricts neuroprotective microglial responses in amyloid beta-mediated pathology. In Alzheimer's & dementia : the journal of the Alzheimer's Association, 19, 4908-4921. doi:10.1002/alz.13089. https://pubmed.ncbi.nlm.nih.gov/37061460/
2. Chou, Vicky, Pearse, Richard V, Aylward, Aimee J, Menon, Vilas, Young-Pearse, Tracy L. 2023. INPP5D regulates inflammasome activation in human microglia. In Nature communications, 14, 7552. doi:10.1038/s41467-023-42819-w. https://pubmed.ncbi.nlm.nih.gov/38016942/
3. Castranio, Emilie L, Hasel, Philip, Haure-Mirande, Jean-Vianney, Liddelow, Shane A, Ehrlich, Michelle E. 2022. Microglial INPP5D limits plaque formation and glial reactivity in the PSAPP mouse model of Alzheimer's disease. In Alzheimer's & dementia : the journal of the Alzheimer's Association, 19, 2239-2252. doi:10.1002/alz.12821. https://pubmed.ncbi.nlm.nih.gov/36448627/
4. Terzioglu, Gizem, Young-Pearse, Tracy L. 2023. Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer's disease. In Molecular neurodegeneration, 18, 89. doi:10.1186/s13024-023-00674-9. https://pubmed.ncbi.nlm.nih.gov/38017562/
5. Karch, Celeste M, Goate, Alison M. 2014. Alzheimer's disease risk genes and mechanisms of disease pathogenesis. In Biological psychiatry, 77, 43-51. doi:10.1016/j.biopsych.2014.05.006. https://pubmed.ncbi.nlm.nih.gov/24951455/
6. Olufunmilayo, Edward O, Holsinger, R M Damian. 2023. INPP5D/SHIP1: Expression, Regulation and Roles in Alzheimer's Disease Pathophysiology. In Genes, 14, . doi:10.3390/genes14101845. https://pubmed.ncbi.nlm.nih.gov/37895194/
7. Iguchi, Akihiro, Takatori, Sho, Kimura, Shingo, Sasaki, Takehiko, Tomita, Taisuke. 2023. INPP5D modulates TREM2 loss-of-function phenotypes in a β-amyloidosis mouse model. In iScience, 26, 106375. doi:10.1016/j.isci.2023.106375. https://pubmed.ncbi.nlm.nih.gov/37035000/
8. Yin, Zhuoran, Rosenzweig, Neta, Kleemann, Kilian L, Holtzman, David M, Butovsky, Oleg. 2023. APOE4 impairs the microglial response in Alzheimer's disease by inducing TGFβ-mediated checkpoints. In Nature immunology, 24, 1839-1853. doi:10.1038/s41590-023-01627-6. https://pubmed.ncbi.nlm.nih.gov/37749326/
9. Dabin, Luke C, Kersey, Holly, Kim, Byungwook, Lamb, Bruce T, Kim, Jungsu. 2024. Loss of Inpp5d has disease-relevant and sex-specific effects on glial transcriptomes. In Alzheimer's & dementia : the journal of the Alzheimer's Association, 20, 5311-5323. doi:10.1002/alz.13901. https://pubmed.ncbi.nlm.nih.gov/38923164/
10. Soni, Disha M, Lin, Peter Bor-Chian, Lee-Gosselin, Audrey, Chu, Shaoyou, Oblak, Adrian L. 2024. Inpp5d haplodeficiency alleviates tau pathology in the PS19 mouse model of Tauopathy. In Alzheimer's & dementia : the journal of the Alzheimer's Association, 20, 4985-4998. doi:10.1002/alz.14078. https://pubmed.ncbi.nlm.nih.gov/38923171/
智鼠故事 
